ArticleResearch square2023

A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM).

Lawrence Kleinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.